Lijun Ning

机构：Shanghai Jiao Tong University, Renji Hospital, Shanghai Cancer Institute, Fourth Affiliated Hospital of Guangxi Medical University, Shanghai Institute of Hematology · ORCID：0000-0001-7646-1784

发表论文 31 篇 · 总被引 1003 次 · h-index 17

代表论文

• Microbiome and metabolome features in inflammatory bowel disease via multi-omics integration analyses across cohorts (2023 · Nature Communications · 被引 257)
• Multi-kingdom gut microbiota analyses define bacterial-fungal interplay and microbial markers of pan-cancer immunotherapy across cohorts (2023 · Cell Host & Microbe · 被引 88)
• Interplay between gut microbial communities and metabolites modulates pan-cancer immunotherapy responses (2025 · Cell Metabolism · 被引 66)
• Disruption of CerS6-mediated sphingolipid metabolism by FTO deficiency aggravates ulcerative colitis (2023 · Gut · 被引 61)
• A specific enterotype derived from gut microbiome of older individuals enables favorable responses to immune checkpoint blockade therapy (2024 · Cell Host & Microbe · 被引 39)
• Synergistic role of gut-microbial L-ornithine in enhancing ustekinumab efficacy for Crohn’s disease (2025 · Cell Metabolism · 被引 35)